Corebridge Financial, Inc. — Form 8-K Summary
Business context and reporting period
Corebridge Financial filed a Form 8-K on June 3, 2024, reporting an underwriting agreement entered into on May 30, 2024. The filing concerns a secondary sale of Corebridge common stock by American International Group, Inc. (AIG), the selling stockholder.
Transaction and key financial terms
- AIG agreed to sell 30,000,000 shares of Corebridge common stock to Morgan Stanley & Co. LLC at $29.05285 per share.
- The stated transaction represents approximately $871.6 million of gross sale proceeds before underwriting discounts, commissions, and expenses.
- AIG granted the underwriter a 30-day option to purchase up to an additional 4,500,000 shares solely to cover over-allotments.
- Because this is a secondary offering, the proceeds are payable to AIG and are not proceeds to Corebridge.
- The filing provides no revenue, profit, cash flow, margin, debt, liquidity, or other operating-performance metrics.
Material changes versus the prior comparable period
The filing does not report period-over-period operating or financial results. The material event is the sale by AIG of a substantial portion of its Corebridge common stock holdings.
Guidance, outlook, risks, contingencies, and unusual items
- The transaction is subject to the terms and conditions of the underwriting agreement.
- The underwriter’s additional-share option is exercisable for 30 days and is limited to covering over-allotments.
- The filing does not provide management guidance, an earnings outlook, or new operating risk disclosures.
- The complete underwriting agreement, a legal opinion regarding the common stock, and related exhibits were filed with the Form 8-K.
Facts investors should verify
- Whether the 30-day over-allotment option was exercised and the final number of shares sold.
- The closing date and net proceeds received by AIG after underwriting discounts and expenses.
- Any resulting changes in AIG’s ownership percentage and Corebridge’s public float.
- The restrictions, representations, indemnities, and other terms contained in the filed underwriting agreement.